Francisco Javier Rubio
Overview
Explore the profile of Francisco Javier Rubio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Memeh E, Ali Y, Javier Rubio F, Hancock C, Haque M
Accid Anal Prev
. 2024 Jul;
206:107720.
PMID: 39024830
Navigating through complex road geometries, such as roundabouts, poses significant challenges and safety risks for drivers. These challenges may be exacerbated when drivers are distracted by mobile phone conversations. The...
2.
Quaresma M, Javier Rubio F, Rachet B
Cancer Epidemiol
. 2024 May;
90:102576.
PMID: 38696968
Background: Cancer survival is a key component to assess the overall effectiveness of healthcare systems in their cancer management efforts. A key supporting tool for planning and decision making was...
3.
Exarchakou A, Rachet B, Lyratzopoulos G, Maringe C, Javier Rubio F
Br J Cancer
. 2024 Apr;
130(12):1960-1968.
PMID: 38671209
Background: More deprived cancer patients are at higher risk of Emergency Presentation (EP) with most studies pointing to lower symptom awareness and increased comorbidities to explain those patterns. With the...
4.
Amaral A, Javier Rubio F, Quaresma M, Rodriguez-Cortes F, Moraga P
Stat Methods Med Res
. 2024 Mar;
33(4):681-701.
PMID: 38444377
Relative survival represents the preferred framework for the analysis of population cancer survival data. The aim is to model the survival probability associated with cancer in the absence of information...
5.
Javier Rubio F, Drikvandi R
Stat Methods Med Res
. 2022 Jun;
31(8):1603-1616.
PMID: 35668699
In many applications of survival data analysis, the individuals are treated in different medical centres or belong to different clusters defined by geographical or administrative regions. The analysis of such...
6.
Javier Rubio F, Alvares D, Redondo-Sanchez D, Marcos-Gragera R, Sanchez M, Luque-Fernandez M
BMC Med Res Methodol
. 2022 Apr;
22(1):95.
PMID: 35369875
Cancer survival represents one of the main indicators of interest in cancer epidemiology. However, the survival of cancer patients can be affected by several factors, such as comorbidities, that may...
7.
Maringe C, Belot A, Javier Rubio F, Rachet B
BMC Med Res Methodol
. 2019 Nov;
19(1):210.
PMID: 31747928
Background: Large and complex population-based cancer data are becoming broadly available, thanks to purposeful linkage between cancer registry data and health electronic records. Aiming at understanding the explanatory power of...
8.
Ampuero E, Cerda M, Hartel S, Javier Rubio F, Massa S, Cubillos P, et al.
Front Pharmacol
. 2019 Aug;
10:804.
PMID: 31379577
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat mood and anxiety disorders. Chronic treatment with this antidepressant drug is thought to favor functional recovery by promoting structural...
9.
Belot A, Ndiaye A, Luque-Fernandez M, Kipourou D, Maringe C, Javier Rubio F, et al.
Clin Epidemiol
. 2019 Jan;
11:53-65.
PMID: 30655705
Survival data analysis results are usually communicated through the overall survival probability. Alternative measures provide additional insights and may help in communicating the results to a wider audience. We describe...
10.
Maringe C, Rachet B, Lyratzopoulos G, Javier Rubio F
Br J Cancer
. 2018 Aug;
119(5):551-557.
PMID: 30108292
Background: Reducing hospital emergency admissions is a key target for all modern health systems. Methods: We analysed colon cancer patients diagnosed in 2011-13 in England. We screened their individual Hospital...